Crossmark

AMPA receptors modulate enhanced dopamine neuronal activity induced by the combined administration of venlafaxine and brexpiprazole

Published Online: 2024-08-15

Published Print: 2024-12

Authors

Daniels, Stephen

El Mansari, Mostafa

Blier, Pierre https://orcid.org/0000-0002-9196-0706
Funding

Funding for this research was provided by:

Gouvernement du Canada | Canadian Institutes of Health Research (PJT-169078)
License Information

Text and Data Mining valid from 2024-08-15

Version of Record valid from 2024-08-15
More Information

Article History

Received: 27 March 2024

Revised: 29 July 2024

Accepted: 1 August 2024

First Online: 15 August 2024

Competing interests

: SD and ME declare no conflict of interest. PB received grant funding and/or honoraria for lectures and/or participation in advisory boards for Lundbeck/ Otsuka and Pfizer.

Document is current